BioMarin Pharmaceutical, Inc. (BMRN)
65.68
+0.17
(+0.26%)
USD |
NASDAQ |
Sep 11, 16:00
65.72
+0.04
(+0.06%)
After-Hours: 20:00
BioMarin Pharmaceutical Price : 65.68 for Sept. 11, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 11, 2026 | 65.96 | 66.05 | 65.28 | 65.68 | 1.605M |
| Sep 10, 2026 | 64.41 | 65.59 | 63.57 | 65.51 | 2.203M |
| Sep 09, 2026 | 63.83 | 65.32 | 63.64 | 64.41 | 1.950M |
| Sep 08, 2026 | 65.24 | 66.26 | 64.01 | 64.63 | 1.458M |
| Sep 04, 2026 | 65.78 | 66.64 | 65.52 | 66.53 | 2.299M |
| Sep 03, 2026 | 67.30 | 67.70 | 66.32 | 66.43 | 1.478M |
| Sep 02, 2026 | 65.00 | 67.20 | 64.99 | 66.97 | 2.521M |
| Sep 01, 2026 | 65.54 | 66.02 | 64.49 | 64.84 | 1.782M |
| Aug 31, 2026 | 65.95 | 66.30 | 64.33 | 65.23 | 2.299M |
| Aug 28, 2026 | 64.99 | 65.08 | 64.07 | 64.66 | 1.098M |
| Aug 27, 2026 | 65.28 | 65.92 | 64.83 | 65.29 | 1.246M |
| Aug 26, 2026 | 65.62 | 66.53 | 65.33 | 65.61 | 1.884M |
| Aug 25, 2026 | 65.03 | 66.36 | 65.02 | 66.12 | 1.358M |
| Aug 24, 2026 | 66.57 | 67.18 | 64.71 | 65.07 | 2.265M |
| Aug 21, 2026 | 67.55 | 68.34 | 66.52 | 66.70 | 1.594M |
| Aug 20, 2026 | 68.11 | 68.75 | 67.56 | 67.68 | 1.276M |
| Aug 19, 2026 | 68.17 | 69.62 | 67.75 | 69.33 | 1.977M |
| Aug 18, 2026 | 67.21 | 68.26 | 66.84 | 66.99 | 1.942M |
| Aug 17, 2026 | 67.00 | 67.63 | 66.21 | 66.64 | 2.238M |
| Aug 14, 2026 | 68.53 | 68.53 | 67.12 | 67.36 | 1.413M |
| Aug 13, 2026 | 70.35 | 70.35 | 68.36 | 68.53 | 2.317M |
| Aug 12, 2026 | 68.71 | 70.98 | 68.29 | 70.24 | 2.841M |
| Aug 11, 2026 | 69.50 | 70.62 | 68.71 | 69.55 | 3.966M |
| Aug 10, 2026 | 64.22 | 69.27 | 63.37 | 68.88 | 5.037M |
| Aug 07, 2026 | 64.82 | 64.92 | 62.20 | 63.81 | 4.365M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Alnylam Pharmaceuticals, Inc. | 248.68 |
| Vertex Pharmaceuticals, Inc. | 515.44 |
| BridgeBio Pharma, Inc. | 72.44 |
| Incyte Corp. | 121.47 |
| Ionis Pharmaceuticals, Inc. | 54.21 |
Price Related Metrics
| PE Ratio | 177.08 |
| PS Ratio | 3.688 |
| Price to Book Value | 2.011 |
| Price to Free Cash Flow | 17.58 |
| Earnings Yield | 0.56% |
| Market Cap | 12.71B |
| Operating PE Ratio | 19.93 |
| Normalized PE Ratio | 33.34 |